Influenza Virus Vaccine for the 2011-2012 Season Announced
The Food and Drug Administration (FDA)'s Vaccines and Related Biological Products Advisory Committee (VRBPAC) met in Bethesda, Md., on Feb. 25, 2011, to select the influenza viruses for the composition of the influenza vaccine for the 2011-2012 U.S. influenza season. During this meeting, the advisory committee reviewed and evaluated the surveillance data related to epidemiology and antigenic characteristics of recent influenza isolates, serological responses to 2010-2011 vaccines, and the availability of candidate strains and reagents.
The committee recommended that vaccines to be used in the 2011-2012 influenza season in the U.S. contain the following:
- A/California/7/09 (H1N1)-like virus*
- A/Perth /16/2009 (H3N2)-like virus
- B/Brisbane/60/2008-like virus
*A/California/7/09 (H1N1)-like virus is the pandemic (H1N1) 2009 influenza virus
This years vaccine for the United States includes the same viruses that were used for the 2010-2011 influenza season and the influenza vaccine composition is identical to that recommended by the World Health Organization on Feb. 17, 2011, for the Northern Hemisphere's 2011-2012 influenza season.
-
Pseudomonas aeruginosa: Infection Risks, Challenges, and Breakthroughs for Health Care Professionals
September 19th 2024Pseudomonas aeruginosa, a highly virulent pathogen, poses significant risks to immunocompromised patients, presenting challenges in treatment due to its antibiotic resistance and environmental persistence.
Advancing Infection Prevention With Diagnostic Innovation: Insights From Alesia McKeown, PhD
September 17th 2024Alesia McKeown, PhD, discusses the pivotal role of cutting-edge diagnostic technologies in enhancing infection prevention, especially in high-risk health care environments, during an interview with Infection Control Today.
The Role of Accurate Testing in Preventing Respiratory Illnesses: Insights from Dr. Aparna Ahuja
September 17th 2024On Get Ready for Flu Day, Dr. Aparna Ahuja discusses the importance of accurate respiratory illness testing, the risks of self-diagnosis, and the role of infection prevention personnel in public health education.
How Cleaning Medical Equipment Directly Affects Patient Safety and Equipment Longevity
September 16th 2024Hospital-associated infections affect over 1 million US patients annually. Proper medical equipment cleaning and sterilization significantly reduce infection risks, improving patient outcomes and safety.
Top 3 Secrets to Effective Infection Prevention and Control Through Strategic MDRO Surveillance
September 13th 2024Sean Brown’s 2024 Disease Prevention Summit presentation emphasized leveraging technology, prioritizing high-risk patients, and environmental surveillance to enhance infection prevention and control strategies.
